Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 440

1.

Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.

Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C; D:A:D study group.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):568-77. doi: 10.1097/QAI.0000000000000523.

PMID:
25763785
2.

Diminished impact of ethnicity as a risk factor for chronic kidney disease in the current HIV treatment era.

Schoffelen AF, Smit C, van Lelyveld SF, Vogt L, Bauer MP, Reiss P, Hoepelman AI, Barth RE; ATHENA National Observational HIV Cohort.

J Infect Dis. 2015 Jul 15;212(2):264-74. doi: 10.1093/infdis/jiv026. Epub 2015 Jan 18.

PMID:
25601941
3.

Emerging themes for sensitivity training modules of African healthcare workers attending to men who have sex with men: a systematic review.

Dijkstra M, van der Elst EM, Micheni M, Gichuru E, Musyoki H, Duby Z, Lange JM, Graham SM, Sanders EJ.

Int Health. 2015 May;7(3):151-62. doi: 10.1093/inthealth/ihu101. Epub 2015 Jan 16. Review.

4.

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA.

Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6.

PMID:
25567330
5.

Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals.

Gras L, de Wolf F, Smit C, Prins M, van der Meer JT, Vanhommerig JW, Zwinderman AH, Schinkel J, Geskus RB; ATHENA national observational cohort and the MOSAIC study.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):536-42. doi: 10.1097/QAI.0000000000000514.

PMID:
25559595
6.

Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria.

Hendriks ME, Bolarinwa OA, Nelissen HE, Boers AC, Gomez GB, Tan SS, Redekop W, Adenusi P, Lange JM, Agbede K, Akande TM, Schultsz C.

J Hypertens. 2015 Feb;33(2):376-684. doi: 10.1097/HJH.0000000000000402.

PMID:
25380164
7.

Feasibility and quality of cardiovascular disease prevention within a community-based health insurance program in rural Nigeria: an operational cohort study.

Hendriks ME, Bolarinwa OA, Wit FW, Brewster LM, Odusola AO, Rosendaal NT, Bindraban NR, Adenusi P, Agbede K, Lange JM, Akande TM, Schultsz C.

J Hypertens. 2015 Feb;33(2):366-75. doi: 10.1097/HJH.0000000000000401.

PMID:
25380163
8.

Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.

Mutwa PR, Boer KR, Asiimwe-Kateera B, Tuyishimire D, Muganga N, Lange JM, van de Wijgert J, Asiimwe A, Reiss P, Geelen SP.

PLoS One. 2014 Nov 3;9(11):e111948. doi: 10.1371/journal.pone.0111948. eCollection 2014.

9.

Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study.

Lange JM, Takashima JR, Peterson SM, Kalapurakal JA, Green DM, Breslow NE.

Cancer. 2014 Dec 1;120(23):3722-30. doi: 10.1002/cncr.28908. Epub 2014 Oct 27.

PMID:
25348097
10.

A joint model for multistate disease processes and random informative observation times, with applications to electronic medical records data.

Lange JM, Hubbard RA, Inoue LY, Minin VN.

Biometrics. 2015 Mar;71(1):90-101. doi: 10.1111/biom.12252. Epub 2014 Oct 15.

11.

The discovery and development of antiretroviral agents.

Lange JM, Ananworanich J.

Antivir Ther. 2014;19 Suppl 3:5-14. doi: 10.3851/IMP2896. Epub 2014 Oct 13. Review.

PMID:
25310317
12.

[Right ventricular septal stimulation would produce similar bi-ventricular dyssynchrony as does apical stimulation in patients with normal ejection fraction].

Lange JM, Manzolillo H, Parras J, Pozzer D, Reyes I, Pantich R.

Arch Cardiol Mex. 2014 Jul-Sep;84(3):183-90. doi: 10.1016/j.acmx.2013.11.008. Epub 2014 Aug 2. Spanish.

PMID:
25091614
13.

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.

Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, Lundgren JD; D:A:D Study Group.

Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8.

PMID:
25042234
14.

Global response to HIV: treatment as prevention, or treatment for treatment?

Sigaloff KC, Lange JM, Montaner J.

Clin Infect Dis. 2014 Jul;59 Suppl 1:S7-S11. doi: 10.1093/cid/ciu267.

15.

Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.

Avihingsanon A, Jitmitraparp S, Tangkijvanich P, Ramautarsing RA, Apornpong T, Jirajariyavej S, Putcharoen O, Treeprasertsuk S, Akkarathamrongsin S, Poovorawan Y, Matthews GV, Lange JM, Ruxrungtham K; HIV-NAT125 study team.

J Gastroenterol Hepatol. 2014 Sep;29(9):1706-14. doi: 10.1111/jgh.12613.

PMID:
24730732
16.

Temporary treatment during primary HIV infection does not affect virologic response to subsequent long-term treatment.

Grijsen ML, Wit FW, Jurriaans S, Kroon FP, Schippers EF, Koopmans P, Gras L, Lange JM, Prins JM; Primo-SHM Study Group.

PLoS One. 2014 Apr 3;9(4):e89639. doi: 10.1371/journal.pone.0089639. eCollection 2014.

17.

Outcomes and utilization of a low intensity workplace weight loss program.

Carpenter KM, Lovejoy JC, Lange JM, Hapgood JE, Zbikowski SM.

J Obes. 2014;2014:414987. doi: 10.1155/2014/414987. Epub 2014 Jan 2.

18.

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.

Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P, Moranne O, Fux CA, Mocroft A, Sabin C, Lundgren JD, Smith CJ; D:A:D study Group.

BMC Nephrol. 2014 Mar 25;15:51. doi: 10.1186/1471-2369-15-51.

19.

Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women.

Landolt NK, Phanuphak N, Ubolyam S, Pinyakorn S, Kerr S, Ahluwalia J, Thongpaeng P, Thammajaruk N, Cremers S, Thomas T, Chaithongwongwatthana S, Lange JM, Ananworanich J.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):e50-2. doi: 10.1097/QAI.0000000000000134. No abstract available.

PMID:
24608892
20.

Effect of health insurance and facility quality improvement on blood pressure in adults with hypertension in Nigeria: a population-based study.

Hendriks ME, Wit FW, Akande TM, Kramer B, Osagbemi GK, Tanovic Z, Gustafsson-Wright E, Brewster LM, Lange JM, Schultsz C.

JAMA Intern Med. 2014 Apr;174(4):555-63. doi: 10.1001/jamainternmed.2013.14458.

PMID:
24534947
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk